SERVICES AND QUALITY
Eurofins Genoma Group commitment and innovation serving you
DOWNLOAD
Service innovation
We offer a wide range of genetic testing and molecular analysis, using cutting-edge technologies such as Next Generation Sequencing. Our offerings range from medical genetics to pharmacogenetics, ensuring advanced diagnostic solutions for a variety of medical and scientific needs.
Centers of Excellence
Our facilities in Rome and Milan are reference centers in the field of molecular diagnostics. Each laboratory is designed to reduce the risk of contamination and improve the effectiveness of testing, ensuring rapid and accurate results.
Transparency and participation
We believe in transparency and active involvement of our clients. We provide full access to examination information and encourage feedback to continuously improve service. Our clients can easily access their results and actively participate in decisions regarding their health.
Data preservation
We protect the privacy of our clients in accordance with the European Privacy Regulation 2016/679 (GDPR), ensuring maximum confidentiality and security of health information.
OFFICES IN ROME AND MILAN
SERVICES OFFERED
- Recurrent abortion: genetic analysis and management of couples with positive history of polyabortion.
- Cytogenetic: diagnosis of chromosomal, numerical or structural alterations.
- Molecular cytogenetics: diagnosis of submicroscopic structural chromosome alterations (array-CGH and FISH technology).
- Cyto-histopathology: analysis of the cell by evaluating its constituents, which allows for the detection of alterations that can be associated with inflammatory-type diseases or viral infections.
- Preimplantation Genetic Diagnosis (PGD): innovative procedure that allows diagnosis of genetic or chromosomal diseases in embryos before implantation.
- Prenatal diagnosis: genetic, cytogenetic, and biochemical tests for investigation of fetal health status during pregnancy.
- Non-invasive prenatal diagnosis:: genetic testing for investigation of fetal health status during pregnancy by analysis of fetal DNA in maternal blood.
- Pharmacogenetics: study of genetic variants that influence response to drug treatments.
- Biochemistry genetics: analysis of specific biochemical markers to assess the risk of chromosomal alterations or genetic diseases.
- Cardiovascular genetics: Evaluation of genetic risk factors predisposing to cardiovascular disease.
- Forensic genetics: DNA analysis from biological traces found at the crime scene.
- Molecular genetics: for pre- and postnatal diagnosis of genetic diseases. Through this service, it is possible to offer genetic analysis afferent to various specialties, including Andrology, Dermatology, Hematology, Endocrinology and Metabolic Diseases, Hepatology, Gastroenterology, Gynecology, Immunology, Nephrology, Neurology, Ophthalmology, Orthopedics, Otolaryngology, Pediatrics, Pneumology, Rheumatology, and Urology.
- Dental genetics: evaluation of genetic risk factors predisposing to dental disease.
- Preventive genetics: analysis of genetic polymorphisms and evaluation of their role in preventive medicine.
- Reproductive genetics: genetic analysis and management of infertile couples.
- Paternity and consanguinity investigations: sophisticated genetic tests to resolve disputed paternity, maternity and consanguinity cases.
- Molecular infectiology: molecular testing for identification, quantitative analysis, and genotyping of infectious agents.
- Next Generation Sequencing: Multiple genetic screening for the diagnosis of heterogeneous genetic diseases using the new "Next Generation Sequencing" technology.
- Nutrigenetics: evaluation of genetic variants that influence the body's intake of nutrients.
- Molecular oncology: genetic testing for early cancer detection and genetic evaluation of predisposition to hereditary cancers.
- Genetic counseling: specialized service that provides support and information to individuals, couples, or families who may be at risk of genetic disease or of passing such conditions on to their descendants. This service includes genetic risk assessments, advice on management and screening or genetic testing options, and emotional and decision-making support during the decision-making process regarding genetic issues.
EQUALITY, CENTRALITY, TRANSPARENCY
MAIN PRINCIPLES
We are firmly committed to equality, the centrality of the individual and transparency in our services. This includes the right to access, information, consent, participation and, where necessary, redress. We continue to improve our structures and procedures to ensure innovation and high quality in health care services.
Why choose Eurofins Genoma Group
Choosing Eurofins Genoma Group means trusting a trusted partner that puts excellence and innovation at the heart of its mission. For your health and the health of your loved ones, rely on our experience and professionalism.
ARE YOU INTERESTED IN LEARNING MORE ABOUT EUROFINS GENOMA GROUP'S INNOVATIVE SERVICES?
Download our full "Service Charter" to explore the details of our activities in genetic diagnosis, genetic counseling and more. Learn more about our commitment to excellence, certified quality and innovation in medical genetics.
DOWNLOAD THE BROCHURE